Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
1 Serum Base
BPC-157 is classified as a Category 2 bulk drug substance as of April 2026, meaning it is prohibited in compounding under Section 503A and 503B
Comparisons between oral semaglutide and other medications not included in the PIONEER program, such as injectable semaglutide, could be considered a limitation of this study because they had different methodologies, dosages, and treatment times
No liability attaches in any way to any actual or alleged injury to any person or any damage to any tangible property if the compounded product is used beyond the scope as prescribed by your physician
Heres the scoop on what might put the brakes on your coverage: Specific Medications : Only certain meds make the cut, so check the list
Staying on treatment is more affordable: After the first month, membership starts at $74 per month when choosing an annual plan
